Page last updated: 2024-09-23

2,5-anhydromannitol

Description

2,5-anhydromannitol: RN given refers to cpd with specified locants [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID73544
SCHEMBL ID389614
MeSH IDM0099587

Synonyms (15)

Synonym
w5dlz1wc4b ,
einecs 255-221-7
d-mannitol, 2,5-anhydro-
unii-w5dlz1wc4b
nsc 129241
2,5-anhydro-d-mannitol
41107-82-8
nsc-129241
(2r,3s,4s,5r)-2,5-bis(hydroxymethyl)oxolane-3,4-diol
2,5-anhydromannitol
(2r,3s,4s,5r)-2,5-bis(hydroxymethyl)tetrahydrofuran-3,4-diol
MCHWWJLLPNDHGL-KVTDHHQDSA-N
SCHEMBL389614
W-202693
F76911

Research

Studies (62)

TimeframeStudies, This Drug (%)All Drugs %
pre-199012 (19.35)18.7374
1990's34 (54.84)18.2507
2000's11 (17.74)29.6817
2010's4 (6.45)24.3611
2020's1 (1.61)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (3.17%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other61 (96.83%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research Highlights

Dosage (2)

ArticleYear
Differential hypoglycemic effect of 2,5-anhydro-D-mannitol, a putative gluconeogenesis inhibitor, in genetically diabetic (db/db) and streptozotocin-induced diabetic mice.
Japanese journal of pharmacology, Volume: 66, Issue: 3
1994
Effects of glucose and fat antimetabolites on norepinephrine turnover in rat hypothalamus and brainstem.
Brain research, Nov-13, Volume: 595, Issue: 2
1992
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]